Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Accord Farma, the Mexican subsidiary of Accord Healthcare, is a prominent pharmaceutical company specializing in the development and commercialization of high-quality generic and biosimilar medicines. As part of the global Intas Pharmaceuticals group, the company leverages extensive research and manufacturing infrastructure to provide affordable therapeutic options across critical areas such as oncology, cardiology, and nephrology. Accord Farma is particularly recognized for its robust portfolio of complex injectables and biosimilars, including treatments for breast cancer and autoimmune disorders. The company operates with a mission to improve patient access to essential medications through a vertically integrated supply chain and a commitment to rigorous quality standards. With a significant presence in the Mexican healthcare market, Accord Farma continues to expand its pipeline to address unmet medical needs in hospital and retail settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Accord Farma.